Two new thiosemicarbazone ligands, 2-propionylthiazole ethylthiosemicarbazone (PTZ-ETSC), and 2-propionylthiazole tert-butylthiosemicarbazone (PTZ-tBTSC), along with their two copper (II) 
Introduction
Thiosemicarbazones are exceptionally versatile multidentate ligands that coordinate to many transition metals with hundreds of papers in the literature discussing their biological activities, their analytical uses, and their ability to coordinate transition metal ions in a variety of oxidation states and geometries [1] [2] [3] [4] [5] . Thiosemicarbazones often act as high affinity bidentate, tridentate, or tetradentate chelating agents depending upon their structural backbone, often losing a hydrazinic proton during chelation to become mono-anionic [1] [6] [7] .
Interestingly, a specific subset of tridentate thiosemicarbazone ligands that have been referred to as α-(N)-heterocyclic thiosemicarbazones have extremely powerful anti-proliferative properties against a wide variety of microbes and cancer cells [8] [9] [10] . Some of these α-(N)-heterocyclic thiosemicarbazones, such as Triapine ® , have potent activity against the enzyme ribonucleotide reductase which catalyzes the conversion of ribonucleotides into deoxyribonucleotides, providing the precursors required for DNA synthesis when a cell is dividing [11] [12] [13] . With their N-N-S tridentate coordination backbone, these α-N-heterocyclic thiosemicarbazones have been shown to chelate to biologically important transition metals, such as Cu(II) and Fe(II) [14] [15] [16] [17] . Coincidentally, literature shows that the copper complexes of several series of tridentate mono-anionic α-(N)-heterocyclic thiosemicarbazones are now known to also exhibit greater antineoplastic activity and work by an entirely different mechanism than the ligands themselves [18] [19] [20] .
Several series of these Cu(II) complexes of α-(N)-heterocyclic thiosemicarbazones including acetylpyridine-thiosemicarbazones, acetylpyrazine-thiosemicarbazones, as well as benzoylpyridine-thiosemicarbazones, have been demonstrated to have high activity against cancer cell lines due to inhibition of the human topoisomerase IIα enzyme [21] [22] . The structural similarity in these three different series of Cu complexes is that they exhibit a slightly distorted square-planar geometry around the metal center, and have a general formula [Cu(TSC)Cl] [19] .
This work expands upon that type research by introducing a previously unknown series of α-(N)-heterocyclic thiosemicarbazones ligands based on a 2-propionyl-thiazole backbone, and their Cu(II) complexes, and shows that the Cu complexes not only inhibit function of human topoisomerase IIα, but have significant activity against two different breast cancer cell lines. The structural representations for these new compounds are shown in Figure 1 . IIα was overexpressed and purified from yeast Saccharomyces cervisiae as described [23] . The enzyme was stored in the buffer with 50 mM Tris (pH7.8), 750 mM KCl, 40% Glycerol and 0.5 mM DTT as 1 mg/mL stock in liquid nitrogen.
Recombinant pBR322 plasmid was amplified and purified following the protocol of Qiagen™ Plasmid Mega Kit.
Instrumentation
The melting points were taken with a Stanford Research Systems Digimelt MPA160, and TLCs were taken with Whatman 250 μm layer PE SIL G/UV po- The UV-Vis data was gathered using a Cary Varian 3E UV-Vis Spectrophotometer. Each sample was diluted to 10 ppm and scanned over a range of 200 -800
nm. All mass spectrometry data was taken with a Varian 300/310/320-MS LC/MS Quadrupole Mass Spectrometer in negative mode using APCI. The corona current was set to −5.00 μA, while the shield potential was set to −600.00
volts. The housing, drying gas, and vaporizer gas temperatures were set to 50˚C, 150˚C, and 350˚C respectively. The drying, nebulizing, and vaporizer gas pressures were each set to 12.0 psi, 55.0 psi, and 17.0 psi. For the mass spectrometry data, each sample was dissolved in minimal amounts of dimethyl sulfoxide and then diluted to 10 ppm in methanol.
Synthesis and Characterization
All reagents and solvents used to synthesize the ligands and the copper complexes were purchased from Sigma-Aldrich or Alfa-Aesar and used without further preparation unless otherwise noted.
Synthesis of PTZ Ligands
PTZ-ETSC:
In a 50 ml round-bottomed flask containing a magnetic stir bar was added 1.045 g (7.40 mmol) of 2-propionylthiazole and 0.8810 g (7.39 mmol) of 4-ethyl-3-thiosemicarbazide. The reagents were dissolved in 30 mL of isopropanol, and 5 mL of a 1% by weight sulfuric acid solution in isopropanol was added to catalyze the reaction. The reaction mixture was heated to 60˚C and stirred for 24 hours. Ratio of H-Bonded Conformer/ Non-H-Bonded Conformer at 1 hour (7.6/1) and at 24 hours (1/1.68). 
Synthesis of Copper Complexes
[Cu(PTZ-ETSC)Cl] Chloro-[N-ethyl-2-[1-(thiazol-2-yl-κN 1 )-propylidene]hydrazinecarbothioamidato-
Crystallographic Data Collection and Structure Determination
Black where the asymmetrical unit C 11 H 17 N 4 S 2 ClCu dimerizes across an inversion center [24] . All non-hydrogen atoms were refined anisotropically. H atoms attached to carbon and nitrogen were positioned geometrically and constrained to ride on their parent atoms. U iso (H) values were set to a multiple of U eq (C) with 1.5 for CH 3 , and U iso (H) values were set to a multiple of U eq (C) and U eq (N) with 1.2 for 
TopoIIα Mediated Relaxation Assay
The assay has been described previously [21] hr prior to drug addition. was then incubated (humidified, 37˚C, 5% CO 2 ) for 24 hr after application of the compounds. Alamar Blue (Thermo Scientific) was then added to each well using complete media as a carrier to attain 8% Alamar blue per well and applied using a multichannel pipette. The plate was then placed back into the incubator and allowed to incubate for approximately 5 hr, after which fluorescence measurements were made at 560 nm excitation and 590 nm emission using the Tecan infinite M200 Pro reader.
Viability Assay of the Ligands and Copper Complexes

Data Analysis
Initial analysis of fluorescence data were performed with Microsoft Excel 2013 normalized by the fluorescence signal from positive controls. Statistical analysis, data fitting, and plot generation was performed with GraphPad Prism 6; norma- 
Results and Discussion
Synthesis of Ligands and Ligand Conformations in Solution
The synthesis of the PTZ-ETSC and PTZ-tBTSC ligands proceeds in good yield to produce clean, crystalline off-white solids. These ligands have some solubility in polar organic solvents such as methanol, ethanol, and isopropanol, and are more soluble in acetone and DMSO; but they are not appreciably soluble in water.
These ligands show evidence of two conformers in solution at equilibrium at room temperature as seen by 1 H NMR. We have shown this type of equilibrium to be between an intramolecular hydrogen-bonded (HB) form and a non-hydrogen bonded (NHB) form for the analogous ligands ATZ-ETSC and ATZ-tBTSC, which has been recently published [25] . and PTZ-tBTSC HB/NHB ratio of 1/1.68) of both conformers.
Copper Complexes
The alpha-(N)-heterocyclic thiosemicarbazones chelate metal ions such as Cu (II) by loss of the hydrazinic proton, which results in a tridentate mono-anionic ligand, and this ligand then becomes planar with apparent resonance stabilization.
The [Cu(PTZ-tBTSC)Cl] complex crystallizes as a S-bridged dimeric form, a type that has been reported in the literature for several similar compounds [26] [27]. The dimeric crystal structure of [Cu(PTZ-tBTSC)Cl] is shown in Figure 3 .
The Cu (II) complexes of α-(N)-heterocyclic thiosemicarbazones seem to generally crystallize in three fashions, 1) as simple square-planar monomers, 2)
as S-bridged dimeric structures, and 3) as halide bridged dimers [27] . The reasons for these types of solid state structures existing as monomers or as dimers for [Cu(TSC)Cl] complexes are unknown, but possible contributing factors are the nature of the heterocyclic ring, the bulkiness of substituents on the ring and the thioamide arm [26] - [32] .
In the dimer there is 3.482 Å between Cu centers, which is consistent with reports in the literature of other similar Cu(II) α-(N)-heterocyclic thiosemicarbazones compounds [27] . It is important to note that the crystal structure is of the 
The Copper(II) Complexes Inhibit TopoIIα-Mediated DNA Plasmid Relaxation
Previous studies have shown that Cu(II) thiosemicarbazone complexes inhibit TopoIIα activities in TopoIIα-mediated DNA plasmid relaxation assays [21] [22]. We tested [Cu(PTZ-ETSC)Cl] and [Cu(PTZ-tBTSC)Cl] inhibition on human TopoIIα, and some of that data is shown in Figure 5 .
The ligands PTZ-ETSC and PTZ-tBTSC didn't show any inhibition of the TopoIIα enzyme at concentrations less than 50 μM, and so aren't included in 
In Vitro Viability Assays
The 
Conclusions
The PTZ-ETSC and the PTZ-tBTSC ligands form two conformers each in the solution state which can best be described as the non-hydrogen-bonded conformer and the hydrogen-bonded conformer. It is not known if the two conformers that are in equilibrium in solution exhibit different biological properties. However, the biological studies presented here show that the PTZ-tBTSC compound has more anti-proliferative action (probably ribonucleotide reductase poisoning, as with Triapine) against both MDA and MCF-7 cancer cell lines studied than its PTZ-ETSC analogue. This could be due to the fact that at equilibrium, the PTZ-tBTSC has a higher ratio of non-hydrogen-bonded conformer than does PTZ-ETSC, however, the tert-butyl group is more lipophilic than the ethyl group, and this difference in lipophilicity may indicate that the PTZ-tBTSC enters the cell more effectively than the PTZ-ETSC.
More importantly, the copper complexes of the ligands are far more effective at inhibition of the Topo enzyme than the ligands themselves, and also inhibit viability of both cancer cell lines more than the ligands. The ligands will not in- 
